Skip to main content
Past Event

New Policy Directions for Biomedical Innovation

Past Event

New Policy Directions for Biomedical Innovation

On November 19, the Engelberg Center for Health Care Reform at Brookings hosted an event examining the outlook and opportunities for biomedical innovation in a challenging fiscal environment. Leaders in the field offered their thoughts on future directions of and policy priorities for the innovation enterprise. Following a brief keynote, a panel of senior thought leaders provided further discussion on actionable next steps to improve biomedical innovation.

Download the executive summary » (PDF)
Download the panelist biographies » (PDF)

Agenda

Welcome

Priorities for Biomedical Innovation in a Challenging Fiscal Environment

Finding the Path Forward for Biomedical Innovation

C

Christopher Austin

Director, National Center for Advancing Translational Sciences - National Institutes of Health

D

Deborah Brooks

Co-Founder and Executive Vice Chairman - The Michael J. Fox Foundation

R

Robert Conley

Regulatory Leader and Distinguished Lilly Scholar - Eli Lilly and Company

J

John Mendelsohn

Professor, Department of Experimental Therapeutics, Division of Cancer Medicine and Director, Khalifa Institute for Personalized Cancer Therapy - The University of Texas MD Anderson Cancer Center

E

Earl Steinberg

Executive Vice President of Innovation & Dissemination - Geisinger Health Solutions

Closing Remarks

More Information

More

Get a weekly events calendar from Brookings